| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/27/2002 | US20020082266 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore |
| 06/27/2002 | US20020082242 Compositions and methods of double-targeting virus infections and cancer cells |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | CA2756207A1 Compositions of estrogen-cyclodextrin complexes |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432839A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2431147A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/27/2002 | CA2431077A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | CA2431074A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (1) |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/26/2002 | EP1216713A1 Compositions of estrogen-cyclodextrin complexes |
| 06/26/2002 | EP1216701A1 Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process |
| 06/26/2002 | EP1216241A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216059A2 Composition for ivf |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | CN1355805A Thienopyrimidines compound |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355035A Conception and childbearing helping band |
| 06/26/2002 | CN1355028A Medicine prepared from extract of pubescent holly root for treating erection disfunction and preparing process thereof |
| 06/26/2002 | CN1355027A Prescription of 'Lujiesu' |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1086694C 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 06/26/2002 | CN1086583C Powder and pellet for strengening yang |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410790 Analgesics |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410602 Method of increasing the production and improving the quality of semen |
| 06/25/2002 | US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410552 Benzoether and related compositions and methods |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/25/2002 | US6410320 Kidney stem cells; for use in treatment of kidney defects |
| 06/25/2002 | US6410249 Odorant receptors |
| 06/25/2002 | US6410007 Erectile dysfunction, vasodilation |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048185A2 Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative |
| 06/20/2002 | WO2002048171A1 Methylene steroids as novel androgens |
| 06/20/2002 | WO2002048169A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047719A2 Survical promoting ncam binding and ncam ligand biding compounds |
| 06/20/2002 | WO2002047701A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/20/2002 | WO2002047694A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | WO2002047692A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 06/20/2002 | WO2002047684A1 Methof for treatment of female sexual dysfunction |
| 06/20/2002 | WO2002047670A1 Treatment of male sexual dysfunction |
| 06/20/2002 | WO2002047603A2 Use of levosimendan for treating erictile dysfunction |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/20/2002 | WO2002024681A3 Pyrazine derivatives as modulators of tyrosine kinases |
| 06/20/2002 | WO2002020495A3 Inhibitors of glycogen synthase kinase 3 |
| 06/20/2002 | WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001053487A3 Human sperm specific lysozyme-like proteins |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | US20020077461 Pharmaceutical formulation |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076710 Detection and treatment of breast disease |
| 06/20/2002 | DE10063106A1 Verfahren zur Herstellung von 2-(2-Ethoxyphenyl)-substituierten Imidazotriazinonen A process for the preparation of 2- (2-ethoxyphenyl) substituted imidazotriazinones |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2431747A1 Treatment of male sexual dysfunction |
| 06/20/2002 | CA2431328A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214601A2 Method for determining the fertility of mammals, especially of humans |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214086A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 06/19/2002 | EP1214076A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 06/19/2002 | EP1213964A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 06/19/2002 | EP1056769B1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0772450B1 Methods for treating bleeding disorders |